MLS-101
Mineralys Therapeutics
[]
mineralys therapeutics presents positive lorundrostat results from the phase 2 target-htn trial at acc.23/wcc - demonstrated clinically meaningful blood pressure reduction in individuals with uncontrolled hypertension obesity was predictive of an enhan... 
CEO Of Digital Media Online